Plasma concentrations of melatonin in panic disorder. 1990

I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia.

Nocturnal plasma melatonin concentrations were measured in seven patients with panic disorder and eight healthy control subjects. The five patients who had never received psychotropic medication had significantly greater melatonin concentrations from 4:00 a.m. to 7:00 a.m. than the control subjects. In addition it is possible that a phase delay occurred in these unmedicated patients. The findings are discussed in terms of previous studies showing increased melatonin in manic patients and the effect of intense stress on melatonin synthesis. The two patients who had been medication free for only 1 week showed a decreased melatonin rhythm, which is consistent with previous findings in medicated patients.

UI MeSH Term Description Entries
D008297 Male Males
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D010200 Panic A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function. Panics
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889

Related Publications

I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
November 1994, Psychiatry research,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
June 2005, Psychiatry research,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
November 1992, The American journal of psychiatry,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
January 1987, Journal of affective disorders,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
July 1993, The American journal of psychiatry,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
February 2007, Therapeutic drug monitoring,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
December 1987, Biological psychiatry,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
December 1984, The American journal of physiology,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
September 1993, Archives of general psychiatry,
I M McIntyre, and F K Judd, and G D Burrows, and S M Armstrong, and T R Norman
October 1992, Biological psychiatry,
Copied contents to your clipboard!